Highly Potent

Aug 10, 2017
By Pharmaceutical Technology Editors
Cambrex is investing $24 Million in new, highly potent API manufacturing capacity at its Charles City, Iowa site.
Aug 03, 2017
By Pharmaceutical Technology Editors
CordenPharma is investing €10 Million in a new line at its Plankstadt, Germany site.
Jul 19, 2017
By Pharmaceutical Technology Editors
ChargePoint Technology is expanding its US presence by opening a new office in San Francisco.
Jun 06, 2017
By Pharmaceutical Technology Editors
Takeda will build a new production facility at its existing Grange Castle site in Ireland.
May 30, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.
May 02, 2017
Pharmaceutical Technology
Advances in chemical synthesis are enabling greener, more cost-efficient processes for API manufacturing.
Mar 16, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Manufacturing will be carried out at the Pfizer Newbridge, Ireland, facility, which is now part of Pfizer CentreOne’s contract manufacturing network.
Mar 02, 2017
Pharmaceutical Technology
The manufacture of highly active or highly hazardous pharmaceutical substances involves a complex interplay between the required threshold values, such as the permitted daily exposure (PDE), which is used to calculate the occupational exposure limit (OEL) and the maximum carry-over from one product to the next. In addition to these threshold values, a risk assessment of the overall process and the associated containment transfer systems, cleaning, and staff training are also important. An account of this complex interplay and how it can be successfully implemented has now been published in the first edition of the International Society for Pharmaceutical Engineering (ISPE) Germany/Austria/Switzerland (D/A/CH) Affiliate's Containment Manual. This article discusses principles of containment, risk assessment, process requirements, technical systems, and other aspects of containment discussed in the manual.
Aug 18, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
CDMO Alcami adds HPAPI capacity and cryogenic capabilities to its Wisconsin facility.
Aug 16, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
native1_300x100
lorem ipsum